V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220007293 | 220011625 | 1.73 | 62.95 | null | 2016-10-25 | 2016-10-26 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 220032097 | CISPLATIN + GEMCITABINE |
| 220007294 | 220011625 | 1.55 | 67.4 | Curative (C) | null | 2016-11-12 | Idarubicin+Tretinoin Spanish Crse1 | Y | N | 220032097 | IDARUBICIN + TRETINOIN |
| 220007295 | 220002854 | 0 | null | Curative (C) | 2016-04-20 | 2016-03-23 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220032099 | CARBOPLATIN + PACLITAXEL |
| 220007296 | 220002855 | 1.8 | null | Palliative (P) | 2016-03-01 | 2016-03-01 | Carboplatin + Paclitaxel (3 weekly) | 2 | null | 220032105 | CARBOPLATIN + PACLITAXEL |
| 220007297 | 220002856 | 1.93 | 72.8 | Palliative (P) | 2015-05-10 | 2015-05-12 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 220032106 | CISPLATIN + GEMCITABINE |
| 220007298 | 220002857 | 0 | null | Curative (C) | 2013-04-16 | 2013-04-16 | AML 18 TRIAL | 1 | N | 220032108 | AML18 TRIAL |
| 220007300 | 220002859 | null | 65.7 | Curative (C) | 2015-11-09 | 2015-11-09 | Dasatinib | N | N | 220032110 | DASATINIB |
| 220007301 | 220002860 | null | 78.55 | Palliative (P) | 2013-10-07 | 2013-09-09 | CARBOPLATIN + PACLITAXEL | N | N | 220032113 | CARBOPLATIN + PACLITAXEL |
| 220007302 | 220002860 | 1.64 | 41 | Palliative (P) | 2016-01-13 | 2016-02-15 | CARBOPLATIN + PACLITAXEL | N | N | 220032113 | CARBOPLATIN + PACLITAXEL |
| 220007303 | 220002861 | 1.75 | 0 | Curative (C) | 2017-06-21 | 2017-06-21 | AML18 PILOT TRIAL | 1 | N | 220032119 | PILOT TRIAL |
| 220007304 | 220002861 | 1.68 | 79 | Curative (C) | 2017-07-22 | 2017-07-22 | AML18 PILOT TRIAL | Y | N | 220032119 | PILOT TRIAL |
| 220007305 | 220002861 | 1.7 | 76.2 | Palliative (P) | 2014-05-24 | 2014-07-11 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 220032119 | CISPLATIN + GEMCITABINE |
| 220007306 | 220002861 | null | 84.3 | Palliative (P) | 2013-09-05 | 2013-09-05 | CARBOPLATIN + PACLITAXEL | N | N | 220032119 | CARBOPLATIN + PACLITAXEL |
| 220007307 | 220002862 | 1.69 | 65.7 | Curative (C) | 2013-11-14 | 2013-11-14 | AML18 PILOT TRIAL | Y | N | 220032126 | PILOT TRIAL |
| 220007308 | 220002862 | 1.71 | 59 | Disease modification (D) | null | 2016-03-29 | AML16 DA 3+10 | N | N | 220032126 | AML16 TRIAL |
| 220007309 | 220002862 | 1.79 | 0 | Palliative (P) | 2015-01-26 | 2015-01-27 | CARBOPLATIN + PACLITAXEL | N | N | 220032126 | CARBOPLATIN + PACLITAXEL |
| 220007310 | 220002862 | 1.68 | 0 | Palliative (P) | 2013-03-01 | 2013-03-01 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 220032126 | CISPLATIN + GEMCITABINE |
| 220007311 | 220002862 | 1.8 | 106 | null | 2016-06-07 | 2016-06-07 | CISPLATIN + GEMCITABINE | 02 | N | 220032126 | CISPLATIN + GEMCITABINE |
| 220007312 | 220002862 | 1.75 | 0 | Palliative (P) | 2017-01-04 | 2017-01-09 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 220032126 | CARBOPLATIN + PACLITAXEL |
| 220007313 | 220002862 | 1.59 | null | Curative (C) | 2017-08-01 | 2017-08-01 | AML 18 Pilot Trial | 1 | N | 220032126 | PILOT TRIAL |
| 220007314 | 220002862 | 1.68 | 47.2 | Palliative (P) | 2016-11-16 | 2016-11-17 | Cisplatin + Gemcitabine (D 1 & 8) | null | N | 220032126 | CISPLATIN + GEMCITABINE |
| 220007315 | 220002863 | 1.6 | 74.8 | Palliative (P) | 2013-06-03 | 2013-06-08 | CARBOPLATIN + PACLITAXEL | 2 | N | 220032147 | CARBOPLATIN + PACLITAXEL |
| 220007316 | 220002864 | 0 | 68 | Curative (C) | 2017-07-08 | 2017-07-08 | AML 18 TRIAL | Y | N | 220032149 | AML18 TRIAL |
| 220007317 | 220011629 | 0 | 89.6 | Disease modification (D) | 2014-03-21 | 2014-03-21 | AML 18 TRIAL | 01 | N | 220032150 | AML18 TRIAL |
| 220007318 | 220011629 | 1.6 | null | Palliative (P) | 2014-01-21 | 2014-01-21 | CISPLATIN + GEMCITABINE | null | N | 220032150 | CISPLATIN + GEMCITABINE |
| 220007319 | 220002865 | null | 98 | Curative (C) | 2014-03-09 | 2014-03-09 | AML18 PILOT TRIAL | N | null | 220032156 | PILOT TRIAL |
| 220007321 | 220002867 | 1.64 | 57 | Palliative (P) | 2014-05-26 | 2014-05-30 | CISPLATIN + GEMCITABINE | 02 | N | 220032158 | CISPLATIN + GEMCITABINE |
| 220007322 | 220002868 | null | 86.5 | Disease modification (D) | null | 2013-06-18 | AML16 Low Dose Cytarabine | null | null | 220032159 | AML16 TRIAL |
| 220007323 | 220002869 | 1.57 | 55.5 | Palliative (P) | 2016-12-08 | 2016-12-08 | GemCarbo Days 1+8 | N | Y | 220032161 | GEMCARBO |
| 220007324 | 220002870 | 1.63 | 70.2 | Disease modification (D) | 2015-08-27 | 2015-08-30 | AML18 PILOT TRIAL | 1 | N | 220032164 | PILOT TRIAL |
| 220007325 | 220002870 | 1.77 | 68 | Curative (C) | 2015-04-22 | 2015-04-23 | AML18 PILOT TRIAL | Y | N | 220032164 | PILOT TRIAL |
| 220007326 | 220002871 | 1.63 | null | Disease modification (D) | 2015-04-03 | 2015-04-04 | Dasatinib | 02 | N | 220032170 | DASATINIB |
| 220007327 | 220002871 | 1.86 | 83.3 | Curative (C) | 2017-06-24 | 2017-06-29 | AML 18 TRIAL | 01 | N | 220032170 | AML18 TRIAL |
| 220007328 | 220002871 | 1.62 | 51.6 | null | 2014-08-03 | 2014-08-03 | AML 18 TRIAL | N | N | 220032170 | AML18 TRIAL |
| 220007329 | 220002871 | 1.72 | 78.7 | Curative (C) | 2017-09-19 | 2017-09-21 | AML 18 TRIAL | 1 | N | 220032170 | AML18 TRIAL |
| 220007330 | 220002871 | 1.69 | 73 | Neo-adjuvant (N) | 2015-12-02 | 2015-12-07 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220032170 | CARBOPLATIN + PACLITAXEL |
| 220007331 | 220002871 | 1.61 | 63.2 | null | null | 2015-12-23 | AML 18 TRIAL | N | N | 220032170 | AML18 TRIAL |
| 220007332 | 220021751 | 1.67 | 14.7 | Curative (C) | 2016-02-03 | 2016-02-03 | AML18 PILOT TRIAL | Y | N | 220032180 | PILOT TRIAL |
| 220007333 | 220002872 | 1.78 | 71.7 | Palliative (P) | 2017-11-01 | 2017-11-07 | Carboplatin + Paclitaxel (weekly) | 02 | N | 220032181 | CARBOPLATIN + PACLITAXEL |
| 220007334 | 220002873 | null | null | Palliative (P) | 2013-06-28 | 2013-06-29 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 220032182 | CISPLATIN + GEMCITABINE |
| 220007335 | 220002874 | 1.75 | 86 | Curative (C) | 2014-04-29 | 2014-05-05 | AML18 PILOT TRIAL | N | N | 220032183 | PILOT TRIAL |
| 220007336 | 220002875 | null | 63.5 | Palliative (P) | 2016-01-30 | 2016-02-03 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220032186 | CARBOPLATIN + PACLITAXEL |
| 220007337 | 220011632 | 1.52 | 67.3 | Curative (C) | 2017-05-19 | 2017-05-19 | AML18 PILOT TRIAL | Y | N | 220032187 | PILOT TRIAL |
| 220007338 | 220011632 | 1.82 | 83.3 | Disease modification (D) | 2014-10-25 | 2014-10-27 | Dasatinib | 02 | N | 220032187 | DASATINIB |
| 220007339 | 220011632 | null | 106 | Palliative (P) | 2017-05-27 | 2017-05-27 | CISPLATIN + GEMCITABINE | 02 | null | 220032187 | CISPLATIN + GEMCITABINE |
| 220007340 | 220002876 | 1.82 | 106 | Curative (C) | 2013-03-10 | 2013-03-16 | AML18 PILOT TRIAL | Y | N | 220032198 | PILOT TRIAL |
| 220007341 | 220002877 | 1.66 | 51.6 | Curative (C) | 2014-05-28 | 2014-05-28 | AML 18 TRIAL | N | N | 220032200 | AML18 TRIAL |
| 220007343 | 220002879 | 1.68 | 65 | Disease modification (D) | 2015-12-08 | 2015-12-12 | AML18 PILOT TRIAL | 1 | N | 220032213 | PILOT TRIAL |
| 220007344 | 220002880 | 1.61 | 59.9 | null | 2017-09-14 | 2017-09-14 | AML16 DA 3+10 | N | N | 220032218 | AML16 TRIAL |
| 220007345 | 220002881 | 1.63 | 70 | Curative (C) | 2016-05-01 | 2016-05-07 | AML 18 TRIAL | 1 | N | 220032221 | AML18 TRIAL |